Cost Curve

Ten More Companies Strike MFN Deals. Everyone Else Yawns.

Brian Reid

How a Program to Bring Obesity Medicines to Medicare Patients Will Bring a Windfall to 340B Hospitals and Clinics

And clear your schedules this afternoon for the latest White House drug pricing fun

Brian Reid

The White House Is Promising a New Set of MFN Deals on Monday, According to Bloomberg

Plus the CMS effort to bring obesity medicines to Medicare is off to a quick start, CVS and Walgreens say

Brian Reid

Real-World Evidence Suggests That Obesity Meds Start Saving Money Within Two Years

And yet another warning sign on rising healthcare costs, this time from large employers

Brian Reid

Dr. Oz Lays Out the Administration’s Drug-Pricing Playbook in CBS Interview

Brian Reid

Healthcare In the United States Has Become Unsustainable (For Real This Time)

And an AHIP graphic underscores the bite middlemen -- especially 340B -- take from each dollar spent on meds

Brian Reid

Comments on Medicare ‘Negotiation’ Help Illuminate Policy Priorities

Brian Reid

How Poor Launch-Price Disclosure Creates Both Immediate and Long-Term Risks

Plus a look at how MFN is impacting drug launches in Canada

Brian Reid

The Government’s Gauge of Inflation Says Drug Prices Are Plummeting. Does That Mean Anything?

Plus important context around data suggesting employers are fleeing the “Big Three” PBMs

Brian Reid